FDA Update

April 2010
Pharmaceutical Representative;Apr2010, Vol. 40 Issue 4, p11
The article offers news briefs involving the U.S. Food and Drug Administration (FDA). The FDA and National Institutes of Health (NIH) created a joint leadership council addressing public health. The agency is working with the European Medicines Agency (EMA) on implementing a streamlined process to help regulators identify and share information on orphan drug and biologic products. Together with non-profit organizations, it also created the Critical Path to Tuberculosis (TB) Drug Regimens.


Related Articles

  • Pediatric Studies of Sodium Nitroprusside Conducted in Accordance With Section 409I of the Public Health Service Act; Establishment of Public Docket. Kux, Leslie // Federal Register (National Archives & Records Service, Office of;10/3/2012, Vol. 77 Issue 192, p60441 

    The article offers information about the opening of a public docket announced by the Food and Drug Administration (FDA). The public docket should report the pediatric studies of sodium nitroprusside that were conducted in accordance with the Public Health Service Act and was submitted to the...

  • FDA provisions push growth in clinical trial registry. Traynor, Kate // American Journal of Health-System Pharmacy;6/1/2009, Vol. 66 Issue 11, p973 

    The article reports that provisions in the U.S. Food and Drug Administration Amendments Act of 2007 (FDAA) which are concerned with the federal clinical trial database, clinicaltrials.gov, have led to an increase in the number of registered trials. According to the article, this should lead to...

  • News in brief.  // Nature Reviews Drug Discovery;Apr2010, Vol. 9 Issue 4, p259 

    The article offers news briefs related to medicine. Genentech Inc., Pfizer Inc., and Biogen Idec Inc. have agreed for a collaboration with academic institutions for the purpose of research and development. The National Institutes of Health and the U.S. Food and Drug Administration have created...

  • FDA, NIH Brace for Sequester Cuts, Public Health Impact. Serebrov, Mari // BioWorld Today;3/ 4/2013, Vol. 24 Issue 41, p1 

    The article reports on the preparation of the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) for the impact of the sequestration on public health. The FDA released an analysis about the effects of the budget cuts on the ongoing activities of the agency....

  • Shuren takes aim at change of culture for Center for Devices. McCARTY, MARK // Medical Device Daily;5/27/2010, Vol. 14 Issue 102, p1 

    The article discusses the changes to be implemented by Jeff Shuren, MD, as director of the Center for Devices and Radiological Health (CDRH), to keep to its mission of promoting public health by keeping unsafe and ineffective devices from the market and assisting appropriate technologies to...

  • NIH inventions translate into drugs and biologics with high public health impact. Chatterjee, Sabarni K; Rohrbaugh, Mark L // Nature Biotechnology;Jan2014, Vol. 32 Issue 1, p52 

    The article focuses on the contributions of the U.S. National Institutes of Health (NIH) Intramural Research Program (IRP) and inventions from public-sector research institutions (PSRIs) to the development of drugs and biologics approved by the U.S. Food and Drug Administration (FDA). It...

  • Margaret A. Hamburg, M.D., Commissioner of Food & Drugs - Remarks at Announcement of FDA/NIH Collaboration.  // Biomedical Market Newsletter;12/20/2010, p394 

    The article presents a speech by Margaret A. Hamburg, commissioner of the U.S. Food & Drugs Administration (FDA), delivered at the Announcement of FDA/NIH Collaboration, held on February 24, 2010, in which she discussed the role of FDA and National Institute of Health (NIH) in promoting public...

  • Research!America: New report illustrates impact of sequestration to medical research.  // Biomedical Market Newsletter;5/12/2012, Vol. 21, p1 

    The article offers information on a report released by Research!America which demonstrates the effect of spending cuts or sequestration on medical research enterprise and public health. The report provides estimated budget cuts for several institutes including the U.S. National Institutes of...

  • Investment Fails to Fuel Biomed Boom. MEILING, BRITTANY // San Diego Business Journal;9/7/2015, Vol. 36 Issue 36, p1 

    The article discusses a study made at Johns Hopkins Bloomberg School of Public Health on public money investments in biomedical research. Topics discussed include drugs approval from the U.S. food and drug Administration, use of the U.S. National Institutes of Health's (NIH) budget for funding...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics